Om du vill rapportera en biverkning gällande en av Lillys produkter, kontakta oss via e-post på DK_PHv@lilly.com eller på telefon +45 4526 6040. Har du ytterligare medicinska frågor gällande en av Lillys produkter, kontakta oss via länken ovan.
Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska
Effect of skipping dose(s)
Tadalafil dosed once daily has been studied in clinical trials for the treatment of erectile
dysfunction (ED), the signs and symptoms of benign prostatic hyperplasia (BPH), and both ED and signs and symptoms of BPH. Once daily dosing allows the achievement of steady state plasma concentration and clinical efficacy was assessed following daily dosing (Cialis SmPC).
The impact of a missed day of therapy has not been studied, but impact on efficacy is likely to vary by patient. Some patients may notice reduced efficacy from missing a single dose, while others may not (Data on file).
REFERENCES
CIALIS EU Summary of Product Characteristics [SmPC], Utrecht, The Netherlands: Eli Lilly Nederland B.V.
Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Datum fӧr senaste ӧversyn 2019 M11 11